The psychomodulatory action of subpyrogenic doses of interleukin-1β in conditions of chronic administration to rats

Neuroscience and Behavioral Physiology

Volumn 37, Issue 5, 2007, Pages 499-504

  Sokolova, E S ^a   Lyudyno, V I ^a   Simbirtsev, A S ^b   Klimenko, V M ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Russian Federation)

^b N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

Behavior; Cytokines; Interleukin 1

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; EMOTIONAL DISORDER; LONG TERM EXPOSURE; MALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PATHOGENESIS; PROTEIN FUNCTION; RAT;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; DRUG ADMINISTRATION SCHEDULE; EXPLORATORY BEHAVIOR; FEVER; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MALE; NEUROIMMUNOMODULATION; RATS; RATS, WISTAR;

EID: 34249053251     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-007-0042-3     Document Type: Article

References (41)

1. V. M. Klimenko and O. Zubareva, "Neurobiology of cytokines, behavior, and adaptive reactions," Ros. Fiziol. Zh. im. I. M. Sechenova, 85, No. 9, 1244-1254 (1999).
2. O. E. Zubareva, V. M. Klimenko, E. M. Efremov, and A. S. Simbirtsev, "Interleukin-1β and depressive states," Ros. Fiziol. Zh. im. I. M. Sechenova, 87, No. 10, 1450-1456 (2001).
3. V. M. Klimenko, O. E. Zubareva, and I. N. Krasnova, "The role of intracerebral interleukin-1 receptors in the modulation of the body's homeostatic reactions,", Neirokhimiya, 12 No. 2, 16-22 (1995).
4. V. M. Klimenko, O. E. Zubareva, and V. I. Lyudyno, "Molecular mechanisms of the formation of illness behavior," in: "Integrative Brain Activity:" International Scientific Congress on Experimental and Applied Physiology [in Russian], Meditsina, Moscow (2001), Vol. 9, pp. 101-106.
5. P. V. Simonov, "Conditioned emotional resonance reactions in rats," in: A Neurophysiological Approach to the Analysis of Intraspecies Behavior [in Russian], Nauka, Moscow (1976).
6. N. M. Khonicheva, I. L. Dmitrieva, N. L. Krushinskaya, and T. A. Voronina, "Individual characteristics of behavior in rats: manifestations of anxiety," Zh. Vyssh. Nerv. Deyat., 34, No. 3, 537-545 (1984).
7. L. Arborelius, M. J. Owens, P. M. Plotsky, and C. B. Nemeroff, "The role of corticotropin-releasing factor in depression and anxiety disorders," J. Endocrinol., 160, 1012 (1999).
8. W. A. Banks, A. J. Kastin, and R. D. Broadwell, "Passage of cytokines across the blood-brain barrier," Neuroimmunomodulation, 2, No. 4, 241-248 (1995).
9. R. M. Bluthe, R. Dantzer, and K. W. Kelley, "Central mediation of the effects of interleukin-1 on social exploration and body weight in mice," Psychoneuroendocrinology, 22, No. 1, 1-11 (1997).
10. R. M. Bluthe, B. Michaud, K. W. Kelley, and R. Dantzer, "Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes," Neuroreport, 7, No. 15-17, 2823-2827 (1996).
11. S. Bonaccorso, S. F. Maier, H. Y. Meltzer, and M. Maes, "Behavioral changes in rats after acute, chronic and repeated administration of interleukin-lbeta: Relevance for affective disorders," J. Affect. Disord., 77, No. 2, 143-148 (2003).
12. K. T. Britton, G. Lee, R. Dana, S. C. Risch, and G. F. Koob, "Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone," Life. Sci., 39, No. 14, 1281-1286 (1986).
13. T. J. Connor, C. Song, B. E. Leonard, Z. Merali, and H. Anisman, "An assessment of the effects of central interleukin-1 beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat," Neurosci., 84, No. 3, 923-933 (1998).
14. F. Crestani, F. Seguy, and R. Dantzer, "Behavioural effects of peripherally injected interleukin-1: Role of prostaglandins," Brain Res., 542, No. 2, 330-335 (1991).
15. R. Dantzer, "Cytokine-induced sickness behaviour: A neuroimmune response to activation of innate immunity," Eur. J. Pharmacol., 500, No. 1-3, 399-411 (2004).
16. R. Dantzer, J. P. Konsman, R. M. Bluthe, and K. W. Kelley, "Neural and humoral pathways of communication from the immune system to the brain: Parallel or convergent?" Auton. Neurosci., 85, No. 1-3, 60-65 (2000).
17. A. J. Dunn and C. W. Berridge, "Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress response?" Brain Res. Rev., 15, 71-100 (1990).
18. A. J. Dunn and A. H. Swiergel, "The role of cytokines in infection-related behavior," Ann. N.Y. Acad. Sci., 840, 577-585 (1998).
19. C. Eriksson, S. Nobel, B. Winblad, and M. Schultzberg, "Expression of interleukin 1 alpha and beta, and interleukin 1 receptor antagonist mRNA in the rat central nervous system after peripheral administration of lipopolysaccharides," Cytokine, 12, No. 5, 423-431 (2000).
20. C. C. Ferri and A. V. Ferguson, "Interleukin-1 beta depolarizes paraventricular nucleus parvocellular neurones," J. Neuroendocrinol., 15, No. 2, 126-133 (2003).
21. G. Griebel, C. Belzung, R. Misslin, and E. Vogel, "The free exploratory paradigm: An effective method for measuring neophobic behavior in mice and testing potential neophobia reducing drugs," Behav. Pharmacol., 4, 637-644 (1993).
22. L. E. Goldstein, A. M. Rasmussen, B. S. Bunney, and R. H. Roth, "Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat," J. Neurosci., 16, No. 15, 4787-4798 (1996).
23. M. Haack, D. Hinze-Selch, T. Fenzel, M. Kuhn, A. Schuld, and T. Pollmacher, "Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis," J. Psych. Res., 33, 407-418 (1999).
24. B. L. Hart, "Biological basis of the behavior of sick animals," Neurosci. Biobehav. Rev., 12, 123-137 (1988).
25. S. C. Heinrichs, F. Menzaghi, P. E. Merlo, K. T. Britton, and G. F. Koob, "The role of CRF in behavioral aspects of stress," Ann. N.Y. Acad Sci., 771, 92-104 (1995).
26. D. N. C. Jones, R. Kortekaas, P. D. Slade, D. N. Middlemiss, and J. J. Hagan, "The behavioral effects of corticotropin-releasing factor-related peptides in rats," Psychopharmacol., 138, 124-132 (1998).
27. J. E. LeDoux, The amygdala: A Functional Analysis, J. P. Aggleton (ed.), Oxford University Press, Oxford (2000), Second Edition, pp. 289-310.
28. G. N. Luheshi, R. M. Bluthe, D. Rushforth, N. Mulcahy, J. P. Konsman, M. Goldbach, and R. Dantzer, "Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats," Auton. Neurosci., 85, No. 1-3, 127-132 (2000).
29. D. O. McCarthy, M. J. Kluger, and A. J. Cander, "Effect of centrally administered interleukin-1 and endotoxin on food intake of fasted rats," Physiol. Behav., 36, No. 4, 745-749 (1986).
30. S. M. Mohan Kumar, C. L. Smith, and P. S. Mohan Kumar, "Central adaptation to chromic administration of interleukin-lbeta (IL-lbeta) in rats," Brain Res. Bull., 62, No. 1, 71-76 (2003).
31. L. L. Moreau, G. Kilpatrick, and F. Jenck, "Urocortin, a novel neuropeptide with anxiogenic-like properties," Neuroreport, 8, No. 7, 1697-1701 (1997).
32. I. G. Otterness, P. A. Seymour, H. W. Golden, J. A. Reynolds, and G. O. Daumy, "The effects of continuous administration of murine interleukine-lα in the rat," Physiol. Behav., 43, 797-804 (1988).
33. P. Parnet, K. W. Kelley, R. M. Bluthe, and R. Dantzer, "Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior," J. Neuroimmunol., 125, 5-14 (2002).
34. J. H. Patton, M. S. Stanford, and E. S. Barratt, "Factor structure of the Barratt impulsiveness scale," J. Clin. Psychol., 51, 768-774 (1995).
35. D. G. Rainnie, R. Bergeron, T. J. Sajdyk, M. Patil, D. R. Gehlert, and A. Shekhar, "Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders," J. Neurosci., 24, No. 14, 3471-3479 (2004).
36. F. Spadaro and A. J. Dunn, "Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment," Bran Behav. Immun., 4, No. 4, 308-322 (1990).
37. N. P. Turin, D. Gayle, S. E. Ilyin, M. C. Flynn, W. Langhans, G. J. Schwartz, and C. R. Plata-Salaman, "Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide," Brain Res. Bull., 54, No. 4, 443-453 (2001).
38. M. M. van Gaalen, M. P. Stenzel-Poore, F. Holsboer, and T. Steckler, "Effects of transgenic overproduction of CRH on anxiety-like behaviour," Eur. J. Neurosci., 15, No. 12, 2007-2015 (2002).
39. H. M. van Praag, "Anxiety and increased aggression as pacemakers of depression," Acta Psych. Scand., 393, Supplement, 81-88 (1998).
40. J. Vaughan, C. Donaldson, J. Bittencourt, M. H. Perrin, K. Lewis, S. Sutton, R. Chan, A. V. Turnbull, D. Lovejoy, C. Rivier, J. Rivier, P. E. Sawchenko, and W. Vale, "Urocortin, a mammalian neuropeptide related to fish urotensin 1 and to corticotropin-releasing factor," Nature, 378, No. 6554, 287-292 (1995).
41. C. A. Winstanley, D. E. H. Theobold, R. N. Cardinal, and T. W. Robbins, "Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice," J. Neurosci., 24, No. 20, 4718-4722 (2004).